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Tumor-associated macrophages (TAMs) and cyclooxygenase-2 (COX-2) are associated with invasion, angio-
genesis, and poor prognosis in many human cancers. However, the role of TAMs in human basal cell carcinoma
(BCC) remains elusive. We found that the number of TAMs infiltrating the tumor is correlated with the depth of
invasion, microvessel density, and COX-2 expression in human BCC cells. TAMs also aggregate near COX-2
expressing BCC tumor nests. We hypothesize that TAMs might activate COX-2 in BCC cells and subsequently
increase their invasion and angiogenesis. TAMs are a kind of M2 macrophage derived from macrophages
exposed to Th2 cytokines. M2-polarized macrophages derived from peripheral blood monocytes were
cocultured with BCC cells without direct contact. Coculture with the M2 macrophages induced COX-2-
dependent invasion and angiogenesis of BCC cells. Human THP-1 cell line cells, after treated with phorbol
myristate acetate (PMA), differentiated to macrophages with M2 functional profiles. Coculture with PMA-treated
THP-1 macrophages induced COX-2-dependent release of matrix metalloproteinase-9 and subsequent
increased invasion of BCC cells. Macrophages also induced COX-2-dependent secretion of basic fibroblast
growth factor and vascular endothelial growth factor-A, and increased angiogenesis in BCC cells.
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INTRODUCTION
Basal cell carcinoma (BCC) is the most common human
cancer; nearly one million new cases occur in the United
States every year (Miller and Weinstock, 1994). BCC usually
grows slowly and rarely metastasizes. If left untreated, BCC
may invade deep layers of the skin and cause local tissue
destruction (Walling et al., 2004). The progression of human
BCC is highly influenced by the host immune response and
the inflammatory cells in the tumor microenvironment (Kaur
et al., 2006; Kaporis et al., 2007). Among the host
inflammatory cells, macrophages play a pivotal role.
Macrophages have functional plasticity and can change
their functional profiles repeatedly in response to environ-
mental changes (Watkins et al., 2007). Like the Th1/Th2
nomenclature, the two extremes of polarized macrophages
are named M1 and M2 macrophages (Martinez et al., 2006).
When macrophages are exposed to lipopolysaccharides (LPS)
and IFN-g, they are polarized to M1 macrophages and have
antitumor activities. When they are exposed to Th2 cyto-
kines, such as IL-4 and IL-13, they are polarized to M2
macrophages and support tumor growth (Mantovani et al.,
2002). M2 macrophages, compared with M1 macrophages,
produce low amounts of tumor necrosis factor-a (TNF-a), IL-
1b, IL-6, and high amounts of transforming growth factor-b
(TGF-b). M2 macrophages also express surface markers such
as CD206 (mannose receptor) and CD204 (scavenger
receptor A) (Mantovani et al., 2004).
Tumor-associated macrophages (TAMs), referring to the
macrophages residing in the tumor microenvironment, are a
kind of M2 macrophage (Sica et al., 2006). TAMs can
promote tumor growth, invasion, metastasis, and activate
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tumor-promoting genes in cancer cells (Chen et al., 2003;
Lewis and Pollard, 2006). Previous reports showed that after
lung cancer cells were cocultured with macrophages in a
noncontact system, cyclooxygenase-2 (COX-2) expression in
lung cancer cells was significantly induced (Chen et al.,
2005). Our previous paper showed that overexpression of
COX-2 in BCC cells promoted tumorigenesis and angiogen-
esis (Tjiu et al., 2006). However, the role of TAMs in human
BCC was not clear. In this report, we show that the number of
TAMs correlated with the depth of invasion and microvessel
counts in human BCC. In addition, we also found that TAMs
aggregated near COX-2-expressing cancer nests in human
BCC. Similar spatial adjacencies were reported in prostate
cancer and hepatocellular carcinoma (Cervello et al., 2005;
Wang et al., 2005). We hypothesize that TAMs might activate
COX-2 in BCC cells and subsequently increase their invasion
and angiogenesis.
We used M2-polarized human THP-1 macrophages and
monocyte-derived M2 macrophages to coculture with BCC
cells without direct contact in a Transwell apparatus. Our
results show that M2 macrophages induced BCC cell invasion
and angiogenesis in a COX-2-dependent manner.
RESULTS
Higher numbers of TAMs correlated with an increased depth of
invasion, angiogenesis, and COX-2 expression in BCC cells
Immunohistochemistry analysis showed conspicuous TAM
aggregations close to COX-2-postitive tumor nests. TAMs also
colocalized with prominent neovascularization in an aggres-
sive (micronodular) subtype of BCC (Figure 1). A higher
number of TAMs was associated with a clear trend of
increasing depth of invasion and a higher microvessel density
(MVD; both Po0.01; Table 1). COX-2 expression in
epithelial cells of human BCC was assayed semiquantitatively
and scored as: grade 0, o10%; grade 1, 10–50%; or grade
2450% for epithelial cells stained positive for COX-2. A
higher number of TAMs also correlated with a higher grade of
COX-2 expression in epithelial cells of human BCC
(P¼0.0001, Kruskal–Wallis test; Table 1). To adjust for the
effects of other clinicopathological factors on the depth of
invasion and MVD, we used a multivariate linear regression
model. Both the number of TAMs and COX-2 expression in
epithelial cells remained significant predictors for invasion
and angiogenesis (Table 2). If the number of TAMs increases
by 1, the predicted depth of invasion will increase by
0.01mm and the predicted MVD will increase by 0.17/high-
power field. If the grade of COX-2 expression increases by 1,
the predicted depth of invasion will increase by 0.62mm and
the MVD will increase by 13.91/high-power fields. These
data suggested an interaction between TAMs and COX-2
expression in BCC cancer cells, with both being important for
BCC invasion and angiogenesis.
PMA treatment differentiated THP-1 cells to M2 macrophages
Human THP-1 cells are widely used as models for monocyte/
macrophages differentiation. When treated with phorbol
myristate acetate (PMA, 320 nM) for 24 hours, THP-1 cells
quickly stopped proliferating, became attached, differentiated
to monocytes (CD14 positive), and subsequently to macro-
phages (CD68 positive; Figure 2a). The PMA-treated THP-1
macrophages exhibited significant expression of M2 macro-
phage surface markers CD206 (mannose receptor) and
CD204 (scavenger receptor A; Figure 2a).
Macrophages had a high degree of functional plasticity as
they could change their functional profiles (from M1 to M2
or M2 to M1) repeatedly depending on the cytokines (Th1
or Th2) to which they were exposed to (Watkins et al., 2007).
If M2 macrophages were exposed to Th1 cytokines, they
were polarized to M1; when M1-polarized macrophages
were exposed to Th2 cytokines, they were polarized to M2.
We hypothesized that PMA-treated THP-1 macrophages
were M2 macrophages. If PMA-treated THP-1 macrophages
were exposed to Th1 cytokines (LPS and IFN-g), they were
polarized to M1 macrophages and would show a M1
cytokine profile. When PMA-treated THP-1 macrophages
were further treated with Th2 cytokines (IL-4/IL-13),
they would remain M2 polarized and have a M2 cytokine
profile. On the basis of this, we generated M1-polarized
THP-1 macrophages by treating THP-1 cells with PMA for
24 hours and polarizing them with Th1 cytokines (20 ngml1
IFN-g and 100ngml1 LPS) for 18 hours (added 6 hours
after PMA). M2-polarized THP-1 macrophages were
obtained from THP-1 cells treated with PMA for 24 hours
with 18-hours treatment of Th2 cytokines (20 ngml1 IL-4
and 20 ngml1 IL-13, added 6 hours after PMA; schema
shown in Figure 2b). The cytokine profiles of the
PMA-treated, M1-polarized, and M2-polarized THP-1
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Figure 1. High number of TAMs located near COX-2-expressing epithelial
cell nests and increased microvessel in BCC. Serial sections showed that
aggressive (micronodular) subtype BCC had increased number of CD68-
positive macrophages aggregated adjacent to COX-2-expressing epithelial
cancer nests. Increased number of CD31-positive microvessels located in area
of dense macrophages infiltration. ( 100; inset  400). Bars¼ 20 mm.
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macrophages were compared. The PMA-treated and M2-
polarized THP-1 macrophages shared the same profile, that is
low TNF-a, IL-1b, IL-6, and high TGF-b, which was exact
opposite to that of M1-polarized THP-1 macrophages (Figure
2b). Taking the cytokine profiles and surface markers
together, PMA treatment induced a M2 response in THP-1
macrophages.
M2-polarized THP-1 macrophages induced COX-2-dependent
invasion and angiogenesis of BCC cells
We then used PMA-treated and M2-polarized THP-1 macro-
phages to coculture with BCC cells in a noncontact system.
The protocol is shown in Figure S1. For PMA-treated THP-1
cells, 1106 THP-1 cells were seeded into upper insert of a
six-well Transwell and treated with 320 nM PMA for 24 hours
(Figure 2c). For M2-polarized THP-1 macrophages, 320 nM
PMA was added to THP-1 cells for 6 hours, followed by PMA
plus 20 ngml1 of IL-4/IL-13 in the following 18 hours (Figure
2c). PMA-containing media were all removed and cells
washed three times in PBS to remove all PMA. PMA-treated
or M2-polarized THP-1 macrophages (in upper inserts) were
then cocultured with BCC cells (in six-well plate) for 6 hours.
After coculture, macrophages (upper inserts) were discarded,
and BCC cells were assayed for invasion and in vitro
angiogenesis.
For invasion assay, BCC cells (in six-well plate) were
seeded into Matrigel-coated invasion chambers (24 wells,
8 mm pore size). After 24 hours, BCC cells were fixed, stained
with crystal violet, and counted for invaded cells. BCC cells
that had been cocultured with PMA-treated or M2-polarized
THP-1 macrophages showed an increased number of invaded
cells (both Po0.05; Figure 2d). However, when BCC cells
Table 1. Increased numbers of TAMs are associated with increased depth of invasion, microvessel density, and
epithelial COX-2 expression in human BCC
Depth of invasion (mm) MVD (no./HPF)1 BCC cells COX-2 expression2,3
Number of TAM/HPF1 n Mean±SD P4 Mean±SD P4 Grade 0 Grade 1 Grade 2
o117 30 1.41±0.95 o0.01* 31.8±14.1 o0.01* 7 20 3
117–215 31 1.76±0.96 44.9±21.3 3 16 12
4215 31 3.32±1.57 85.6±21.5 0 2 29
Total 92 2.17±1.45 54.4±29.9 10 38 44
MVD, microvessel density; TAMs, tumor-associated macrophages; COX-2, cyclooxygenase-2; HPF, high-power field; SD, standard deviation.
1Number of TAMs in  200HPF was divided into tertiles.
2COX-2 expression in human BCC cells was assayed semiquantitatively and scored as: grade 0,o10%; grade 1, 10–50%; grade 2450% for BCC cells that
stained positive for COX-2.
3Kruskal–Wallis test; P=0.0001.
4Test for trend of ordered categories; Po0.05 (*) was considered significant.
Table 2. Multivariate linear regression analysis identified the number of TAMs and the grade of COX-2 expression
as a significant predictor for depth of invasion and MVD in human BCC
Invasion depth (mm) MVD (no./ HPF)
Characteristics1 Coefficient SE P-value2 Coefficient S E P-value2
Age (years) 0.00 0.01 0.61 0.06 0.12 0.59
Sex (male/female) 0.05 0.21 0.82 3.08 3.21 0.34
Head and neck location vs non-head and neck location 0.48 0.27 0.09 0.89 4.19 0.83
Aggressive vs nonaggressive histological subtypes 0.19 0.23 0.42 7.98 3.49 0.03*
Grade of BCC cells COX-2 expression 0.62 0.21 o0.01* 13.91 3.28 o0.01*
Number of TAM/ 200 HPF 0.01 0.00 o0.01* 0.17 0.02 o0.01*
Tumor diameter 0.13 0.24 0.58 1.67 3.69 0.65
Recurrent vs primary BCC 0.03 0.51 0.96 6.86 7.77 0.38
With vs without history of skin cancer (other than BCC) 0.71 0.45 0.12 2.77 6.34 0.69
With vs without history of radiotherapy 1.19 0.68 0.08 8.99 10.43 0.39
TAMs, tumor-associated macrophages; COX-2, cyclooxygenase-2; MVD, microvessel density; BCC, basal cell carcinoma; HPF, high-power field; SE,
standard error.
1Age, macrophage density, and tumor diameter (mm) were continuous variables. Head and neck location, aggressive histological subtype, recurrent BCC,
history of skin cancer (other than BCC), and history of radiotherapy were ordinal variables. Grade of COX-2 expression is categorical.
2Po0.05 (*) is regarded as significant.
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were transiently transfected with COX-2 siRNA or pretreated
with celecoxib (10 mM) for 30minutes before they cocultured
with macrophages, the increments were abrogated (all
Po0.05; Figure 2d).
For the in vitro angiogenesis assay, BCC cells that had
been cocultured with macrophages were washed and serum-
free RPMI 1640 were added. At 24 hours later, BCC culture
supernatants (conditioned media) were collected. Concen-
trated conditioned media (10-fold) were added to human
umbilical vein endothelial cells (HUVECs). The numbers of
tube-like structures formed by HUVECs were determined
6 hours later. The supernatants derived from BCC cells that
had been cocultured with PMA-treated or M2-polarized
THP-1 macrophages showed increased numbers of tube-like
structures of HUVECs (both Po0.05; Figure 2e). The
increments were blocked by transiently transfecting BCC
cells with COX-2 siRNA or treating BCC cells with celecoxib
(10 mM) 30minutes before coculture (all Po0.05; Figure 2e).
These results suggested M2 macrophages induced a COX-2-
dependent invasion and angiogenesis in human BCC cells.
TAMs activate p38 MAPK/NF-jB/COX-2 cascades and induce
MMP-9/VEGF-A/bFGF expression
Significant induction of COX-2 mRNA was found in BCC
cells that had been cocultured with PMA-treated or M2-
polarized THP-1 macrophages (both Po0.05; Figure 3a). To
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Figure 2. M2-polarized THP-1 macrophages induced COX-2-dependent invasion and angiogenesis of human BCC. (a) THP-1 cells treated with 320 nM PMA for
24 hours showed significant induction for CD14 (marker for monocyte differentiation), CD68 (marker for macrophages differentiation), CD206, and CD204
(both markers for M2 macrophages). (b) After treatment with 320 nM PMA for 24 hours, THP-1 cells differentiated to the ‘‘PMA-treated THP-1 macrophages’’
(labeled ‘‘PMA only’’). For the ‘‘M1-polarized THP-1 macrophages’’ (M1), THP-1 cells were treated with PMA for 6 hours and then cultured with PMA plus
100 ngml1 LPS and 20 ngml1 IFN-g for the following 18hours. For the ‘‘M2-polarized THP-1 macrophages’’ (M2), THP-1 cells were treated with PMA for
6 hours, then cultured with PMA plus 20 ngml1 IL-4 and 20 ngml1 IL-13 for another 18 hours. PMA-treated THP-1 macrophages (PMA only, black bars) and
M2-polarized THP-1 macrophages (M2, hatched bars) both had significantly lower levels of TNF-a, IL-1b, and IL-6, and a higher level of TGF-b compared with
that of M1-polarized THP-1 macrophages (M1, white bars; all Po0.05; *, PMA only vs M1; # M2 vs M1). (c) For coculture experiments, 1 106 THP-1 cells were
seeded into upper inserts (in a six-well plate) and treated with 320 nM PMA for 24 hours; these cells became ‘‘PMA-treated THP-1 macrophages’’. For ‘‘M2-
polarized THP-1 macrophages’’, 1 106 THP-1 cells were seeded into upper inserts, treated with PMA for 6 hours, and then cultured with PMA plus 20 ngml1
IL-4/IL-13 for 18 hours. Both PMA-treated and M2-polarized THP-1 macrophages were washed thoroughly to remove all PMA and then cocultured with BCC
cells (2105 cells per well) in six-well plates for 6 hours. (d, e) BCC cells that had been cocultured with either PMA-treated THP-1 macrophages (black bars) or
M2-polarized THP-1 macrophages (hatched bars) showed a significant increase in the number of invaded cells and tube-like structures (both Po0.05; *, PMA-
treated THP-1 macrophages vs no coculture; #, M2-polarized THP-1 macrophages vs no coculture). The increments were abrogated by transient transfection of
COX-2 siRNA or 30minutes celecoxib (10 mM) treatment to BCC cells before they cocultured with both PMA-treated or M2-polarized THP-1 macrophages (all
Po0.05; D, COX-2 siRNA vs coculture only; Y, celecoxib 10mM vs coculture only).
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evaluate the transcriptional regulation of COX-2, we trans-
fected COX-2 promoter construct (327/þ59) or consensus
sequence-mutated constructs into BCC cells and then
cocultured BCC cells with THP-1 macrophages. We found
that BCC cells transfected with nuclear factor-kB (NF-kB)
consensus sequence mutated constructs, but not with nuclear
factor NF-IL6- or cAMP-responsive element-mutated con-
structs, blocked luciferase activity induced by coculture
(Figures 3b and Figure S2a). To determine which signaling
pathway regulates NF-kB activity, BCC cells were transfected
with NF-kB reporter plasmids and pretreated with specific
inhibitors, including SB203580 (p38 MAPK inhibitor, 10 mM),
PD98059 (ERK inhibitor, 25 mM), LY294002 (PI3K inhibitor,
25 mM), and SP600125 (JNK inhibitor, 10 mM) for 30minutes
before coculture with the PMA-treated THP-1 macrophages.
Only pretreatment with SB203580 (10 mM) blocked NF-kB
luciferase activity induced by coculture (Po0.05, Figures 3c
and S2b). COX-2 mRNA induction was also consistently
blocked by pretreatment of SB203580 (10 mM) and Bay 11-
7082 (NF-kB inhibitor, 5 mM) (both Po0.05, Figure 3d).
Taken together, these results suggest that macrophages
induce COX-2 expression in BCC cells via the p38 MAPK/
NF-kB cascade.
Degradation of the extracellular matrix by matrix metallo-
proteinases (MMPs) is important in BCC invasion (Kerkela¨ and
Saarialho-Kere, 2003). We found that after coculture with the
PMA-treated THP-1 macrophages, the number of invaded
cells increased significantly in chambers coated with gelatin,
but not fibronectin or collagen I (Figure 3e). This implies that
macrophages induced gelatinase activity in BCC cells. We
then found that macrophages induced significant secretion of
MMP-9 (gelatinase-B), but not MMP-2 (gelatinase-A), from
BCC cells (Figure 3f). When MMP-9 activity was blocked by a
specific inhibitor before coculture, the number of invaded
cells was significantly abrogated (Figure 3g). Taken together,
macrophages might induce MMP-9 in BCC cells and
subsequently increase the invasiveness of BCC cells.
Basic fibroblast growth factor (bFGF) and vascular
endothelial growth factor-A (VEGF-A) were previously
identified as downstream effectors in COX-2-overexpressing
BCC cells (Tjiu et al., 2006). We found synergistic abrogation
of in vitro angiogenesis by addition of bFGF and VEGF-A
neutralizing antibodies into conditioned media (all Po0.05,
Figure 3h). These results suggest that macrophages induce
angiogenesis of BCC cells by VEGF-A and bFGF induction.
Monocyte-derived M2 macrophages also induced
COX-2-dependent invasion and angiogenesis of BCC cells
To generalize our findings, we isolated monocytes from
human peripheral blood mononuclear cells by magnetic cell
sorting using CD14 microbeads. Macrophages were obtained
by culturing monocytes (98% CD14þ ) for 6 days in RPMI
1640 supplemented with 20% fetal calf serum (FCS) and
100ngml1 macrophage colony-stimulating factor at a
density of 1.5 105 cells per cm2 (Martinez et al., 2006).
For M2 polarization, cells were then treated with 20 ngml1
IL-4 and 20 ngml1 IL-13 for 3 days (Martinez et al., 2006);
whereas for M1 polarization, macrophages were treated with
100 ngml1 LPS and 20 ngml1 IFN-g for 3 days. Monocyte-
derived M2 macrophages secreted low levels of TNF-a, IL-1b,
and IL-6 and high level of TGF-b compared with their M1
counterparts (Figure S3). CD206 and CD204 were highly
expressed on the cell surfaces of the ‘‘monocyte-derived M2
macrophages’’ (data not shown).
Two (2) 105 monocyte-derived M2 macrophages were
then seeded into upper inserts and cocultured with 2105
BCC cells (in six-well plates) in serum-free RPMI 1640 for
24 hours. After coculture, macrophages (in upper inserts)
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were discarded. BCC cells were assayed for COX-2 mRNA,
invasion and in vitro angiogenesis, as described previously.
COX-2 mRNA was significantly induced at 24 hours after
coculture with monocyte-derived M2 macrophages (Po0.05;
Figure 4a). An increased number of invaded cells were found
in BCC cells that had been cocultured with the monocyte-
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Figure 3. Macrophages activated a p38 MAPK/NF-jB/COX-2 cascade and induced MMP-9-dependent invasion and VEGF-A/bFGF-dependent angiogenesis in
BCC cells. (a) After BCC cells were cocultured with PMA-treated THP-1 macrophages (black bar) or M2-polarized THP-1 macrophages (hatched bar) for 6 hours,
real-time quantitative PCR revealed that COX-2 mRNA was significantly induced in BCC cells (both Po0.05; *, coculture with PMA-treated THP-1 macrophages
vs no coculture; #, coculture with M2-polarized macrophages vs no coculture). (b) BCC cells were transiently transfected with COX-2 promoter luciferase
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SB203580 vs no inhibitor; Y, Bay 117082 vs no inhibitor). (e) After coculture with PMA-treated THP-1 macrophages, BCC cells had increased numbers of
invaded cells in chambers coated with gelatin (Po0.05; *, coculture vs no coculture), but not fibronection or collagen I. (f) Coculture with PMA-treated THP-1
macrophages also induced significant secretion of MMP-9 from BCC cells (Po0.05; * coculture vs no coculture). (g) MMP-9 specific inhibitor significantly
abrogated macrophage-induced invasiveness of BCC cells (Po0.05; #, MMP-9 inhibitor vs no coculture). (h) Adding neutralizing antibodies to VEGF-A and
bFGF synergistically abrogated in vitro angiogenesis (tube-like structures formation of HUVECs; all Po0.05; #, anti-VEGF-A vs no; Y, anti-bFGF vs no; D, anti-
VEGF-A/bFGF vs no).
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derived M2 macrophages (Po0.05; Figure 4b). The incre-
ments were abrogated by COX-2 siRNA and celecoxib
(10 mM) pretreatments (both Po0.05; Figure 4b). Conditioned
media from BCC cells that had been cocultured with the
monocyte-derived M2 macrophages resulted in increased
number of tube-like structures of HUVECs (Po0.05; Figure
4c). The increase was abrogated by COX-2 siRNA and
celecoxib (10mM) pretreatments (both Po0.05; Figure 4c). To
determine whether MMP-9, VEGF-A, and bFGF secretion
from BCC cells were activated by coculture with monocyte-
derived M2 macrophages. BCC cells that had been cocul-
tured with monocyte-derived M2 macrophages were washed
and serum-free media were added. Serum-free culture
supernatants were collected at 24 hours and assayed by
ELISA. Coculture induced increased release of MMP-9,
VEGF-A, and bFGF from BCC cells, which could be
abrogated by pretreating BCC cells with COX-2 siRNA or
celecoxib (10 mM; Figure S4). Taken together, coculture with
monocyte-derived M2 macrophages also induced COX-2-
dependent invasion and angiogenesis of BCC cells.
DISCUSSION
We found that TAMs can induce invasion and angiogenesis of
human BCC. TAMs were derived from circulating monocytes
that are recruited at the tumor site by chemotactic factors
(Balkwill et al., 2005). A tumor microenvironment abundant in
Th2 cytokines facilitated BCC progression (Kaporis et al.,
2007). However, the Th1 immune response induced by a
topical immune modifier (imiquimod) caused BCC regression
(Wenzel et al., 2005). We focused on the effect of TAMs on
cancer cells, and limited this study to effects mediated by
paracrine regulation. We used a noncontact system described
previously for coculture macrophages and BCC cells (Chen
et al., 2003, 2005). THP-1 macrophages were used as a
macrophage model because PMA-treated THP-1 macrophages
had an M2 functional profile (Chen et al., 2003, 2005).
No PMA-containing macrophages or media were added to
the coculture. PMA used to differentiate THP-1 cells was
discarded and the PMA-treated cells were thoroughly washed
(three times in PBS) to remove all PMA before they cocultured
with BCC cells. To rule out the possibility that BCC cells
might have been activated by trace PMA contamination, we
fixed the PMA-treated THP-1 macrophages with 4% paraf-
ormaldehyde for 30minutes at 4 1C. The paraformaldehyde-
fixed (killed) macrophages washed with the same protocol,
and then cocultured with BCC cells. We found that once the
macrophages were killed, they could no longer induce
invasion, in vitro angiogenesis, or COX-2 expression in
BCC cells (Figure S5). If BCC cells had been activated by
trace contamination of PMA directly, we would have seen
significant induction of invasion, angiogenesis, and COX-2
expression, even after macrophage activities were ablated.
This suggests that BCC cells were activated by THP-1
macrophage activity instead of contamination by PMA.
To further confirm that BCC cells were activated by THP-1
macrophage activity, we replaced THP-1 cells with primary
human skin fibroblasts. All the experimental protocols were
the same, except that THP-1 cells were replaced by
fibroblasts. BCC cells cocultured with PMA-treated fibro-
blasts did not show significant induction of invasion, in vitro
angiogenesis, or COX-2 expression comparing with BCC cells
cocultured with fibroblasts without PMA treatment (Figure
S5). Had the BCC cells been activated by PMA contamina-
tion, coculture with PMA-treated fibroblasts should have
induced similar responses in invasion, angiogenesis, and
COX-2 expression even without macrophages. However, our
results suggest that the presence of THP-1 macrophages was
essential for BCC cell activation. This argued against the
conjecture that BCC cells were activated directly by PMA.
The truly PMA-free ‘‘monocyte-derived M2 macrophages’’
induced the same responses in BCC cells as the ‘‘PMA-treated
THP-1 macrophages’’ did. These findings ruled out the
possibility that BCC cells were activated directly by trace
PMA contamination.
TAMs can directly activate tumor-promoting genes in cancer
cells (Chen et al., 2003, 2005). Consistent with previous
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Figure 4. Monocyte-derived M2 macrophages also induced COX-2-dependent invasion and angiogenesis of human BCC cells. Monocyte-derived M2
macrophages were obtained from peripheral blood monocytes treated with 100 ngml1 M-CSF for 7 days, followed by 20ngml1 IL-4 and 20ngml1 IL-13 for
3 days. Monocyte-derived M2 macrophages (2105) were seeded into upper inserts and cocultured with BCC cells (2 105 cells per well) in six-well plate for
24 hours. After coculture, macrophages were discarded. BCC cells were washed and assayed for COX-2 mRNA expression, invasion, and in vitro angiogenesis
(HUVEC tube formation assay). Coculture induced significant COX-2 mRNA expression (a), invasion (b), and in vitro angiogenesis (c) (Po0.05; *, coculture vs
no coculture). Pretreating BCC cells with COX-2 siRNA or celecoxib abrogated M2 macrophage-induced invasion and angiogenesis (all Po0.05; #, COX-2
siRNA vs coculture only; Y, celecoxib vs coculture only).
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reports, we found that COX-2 mRNA induction by macro-
phages was highly regulated by the binding of NF-kB to its
consensus sequences in the promoter region (Chang et al.,
2004). Macrophages also induce invasiveness via NF-kB in
breast and ovarian cancers (Hagemann et al., 2005). Macro-
phages activate p38 MAPK/NF-kB/COX-2 cascades in BCC
cells, as corroborated by a previous report (Hung et al., 2004).
The expression of MMP-1, 2, 3, 7, 9, 10, and 13
was previously reported in human BCC (Kerkela¨ and
Saarialho-Kere, 2003). The reverse transcription–PCR results
showed that only MMP-9 (and no other MMPs) was induced
in BCC cells after coculture with macrophages (data not
shown). Macrophages also activate MMP-9 activity in lung
and breast cancer cells (Hagemann et al., 2004; Chen et al.,
2005). In this report, we found macrophage-induced
secretion of MMP-9 and MMP-9 enzymatic activity (detected
by zymography) from BCC cells, which were blocked by
p38 MAPK/NF-kB/COX-2 inhibition (Figure S6). Clinically,
we detected MMP-9 expression in BCC cancer cells by
immunohistochemistries (Figure S7). We found higher grade
MMP-9 expression in BCC cancer cells, which correlated
with increased depth of invasion, the number of TAMs, and
epithelial COX-2 expression in BCC (all Po0.05, Table S1).
Taken together, it appears that MMP-9 is responsible for
increased invasion induced by macrophages.
Angiogenesis is essential to invasion and metastasis of
many human cancers. Although BCC is a nonmetastatic
tumor, formation of new vessels is also essential for the
invasion of human BCC. We found that higher MVD
correlated with deeper tumor invasion in human BCC cells
(r¼0.7144, Po0.0001, Spearman’s rank correlations test).
We previously reported that COX-2 overexpression induced
bFGF and VEGF-A expression (Tjiu et al., 2006). Here, we
also demonstrated that these two angiogenic factors are
important in TAM-induced angiogenesis of human BCC cells.
In addition, in vitro angiogenesis, as well as VEGF-A and
bFGF release from BCC cells after activation by macrophage
coculture, was regulated by p38 MAPK/NF-kB/COX-2
cascades (Figure S8). bFGF and VEGF-A were also detected
in human BCC cancer cells, further highlighting their clinical
significance (Oh et al., 2003).
In summary, we found that TAMs increased the invasion
and angiogenesis of human BCC. Macrophages could induce
BCC cells to release MMP-9, VEGF-A, and bFGF to support
tumor cell invasion and angiogenesis in a COX-2-dependent
manner. The targeting of TAMs as a therapeutic approach has
been investigated in breast cancer and melanoma (Luo et al.,
2006; Gazzaniga et al., 2007). Targeting TAMs or polarizing
TAMs toward tumor-killing phenotypes by immune modula-
tion may be a nonsurgical method to treat human BCC in the
near future.
MATERIALS AND METHODS
Patients and specimens
The medical ethical committee of the National Taiwan University
Hospital approved all described studies. The study was conducted
according to Declaration of Helsinki Principles. Participants gave their
written informed consent. A total of ninety-two patients (92 speci-
mens), who received surgical excision of a BCC in the Department of
Dermatology, National Taiwan University Hospital from 1999 to
2004, were enrolled in this study. Archived paraffin-embedded
sections were collected from the Department of Pathology, National
Taiwan University Hospital. Clinical characteristics were collected
retrospectively by reviewing the patients’ medical records.
Immunohistochemistry and evaluation of COX-2 expression,
microvessel density, macrophage density, and depth of invasion
Using a standard ABC technique, antihuman COX-2 antibody (1:40
dilution; Cayman Chemical, Ann Arbor, MI), CD31 antibody (1:100
dilution; Dako, Carpinteria, CA), CD68 antibody (1:100 dilution;
Dako), and MMP-9 (1:50 dilution; Santa Cruz Biotechnology, Santa
Cruz, CA) were applied on 92 BCC paraffin sections and localized
with 3,3-diaminbenzidine tetrahydrochloride, followed by counter-
staining with hematoxyline. COX-2 and MMP-9 were scored by a
semiquantitative system, that is grade 0, o10%; grade 1, 10–50%;
grade 2450% positive cells. MVD were evaluated by averaging the
number of microvessels found in 10 selected high-power fields
( 200 magnification) where the most CD31 staining was seen. The
number of TAMs was determined by averaging the number of TAMs
in 10 high-power fields where the most CD68 staining was observed.
The depth of invasion (mm) was determined as the vertical distance
from the deepest lower margin to the epidermis of the BCC.
Cell preparations
The human BCC cell line was tested free of mycoplasma and other
trivial contaminants. THP-1 cells were obtained from ATCC
(Manassas, VA). Both BCC and THP-1 cells were cultured in RPMI
1640 (Invitrogen, Carlsbad, CA) supplemented with 10% FCS,
100mgml1 penicillin, and 100mgml1 streptomycin.
To generate PMA-treated THP-1 macrophages, 1 106 THP-1
cells were seeded into the upper insert of a six-well Transwell
apparatus (0.4 mM pore size, Corning, Lowell, MA) and treated with
PMA (320 nM) for 24 hours (Figure S1). To generate M2-polarized
THP-1 macrophages, THP-1 cells were treated with 320 nM PMA for
6 hours, and then cultured with PMA plus 20 ngml1 IL-4 and
20 ngml1 IL-13 for another 18 hours (Figure S1). To generate M1-
polarized THP-1 macrophages, THP-1 cells were treated with
320 nM PMA for 6 hours and then cultured with PMA plus
100 ngml1 LPS and 20 ngml1 IFN-g for 18 hours.
Monocyte-derived M2 macrophages were generated as described
previously (Martinez et al., 2006). Briefly, human peripheral blood
mononuclear cells were isolated using density gradient centrifuga-
tion. Monocytes (498% purity) were isolated using anti-CD14
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Macro-
phages were obtained by culturing monocytes for 6 days in RPMI
1640 supplemented with 20% FCS and 100 ngml1 macrophage
colony-stimulating factor at a density of 1.5 105 per cm2.
Macrophage polarization was obtained by removing the culture
media and culturing cells for an additional 72 hours in RPMI 1640
supplemented with 5% FCS and 100ngml1 LPS plus 20 ngml1
IFN-g (for M1 polarization) or 20 ngml1 IL4 plus 20 ngml1 IL-13
(for M2 polarization).
Human skin fibroblasts were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) containing 25mM Hepes, 100Uml1
penicillin, 100mgml1 streptomycin, and 10% FCS at 37 1C in a 5%
CO2 humidified incubator.
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Macrophage and BCC cell coculture
After a thorough wash to remove all PMA, PMA-treated THP-1
macrophages or M2-polarized THP-1 macrophages (upper inserts)
were cocultured with BCC cells (in a six-well plate, 2 105 cells per
well) without direct contact (Figure S1). After 6 hours of coculture,
upper inserts containing macrophages were discarded, and BCC
cells were washed and then used for subsequent experiments.
Monocyte-derived M2 macrophages (2 105) were seeded into
upper inserts and cocultured with BCC cells (2 105 cells per well)
in a six-well plate. After 24 hours of coculture, the upper inserts were
discarded, and BCC cells washed and used for subsequent
experiments.
Flow cytometry
After blocking human FcRs, cells were washed and resuspended in
PBS supplemented with 1% heat-inactivated FBS and 0.01% NaN3.
For CD68 staining, cells were fixed and permeabilized with a BD
Cytofix/CytopermTM Fixation/Permeabilization Solution Kit (BD
Biosciences, Franklin Lakes, NJ). Cells were then incubated with
the FITC-CD68 mAb (Dako). For surface markers, cells were
incubated with FITC-CD14 mAb (BD Biosciences), or PE-CD206
mAb (BD Biosciences). For detection of CD204, cells were
incubated with antihuman CD204 mAb (R&D systems, Minneapolis,
MN), washed, and labeled with PE-conjugated goat anti-mouse
secondary antibody. Following the final washing step, labeled cells
were analyzed by flow cytometry on a FACScan flow cytometer
using CellQuest software (BD Biosciences).
Plasmid transient transfection and luciferase activity assay
The COX-2 promoter (327/þ 59), NF-kB (223/214)-binding site
mutated, NF-IL6-binding site (132/124) mutated, or cAMP-
responsive element-binding site (59/53) mutated constructs were
obtained from Dr Inoue (Nara University, Nara, Japan). The NF-kB
luciferase reporter was obtained from Clontech (Mountain View,
CA). BCC cells were transfected with COX-2 promoter constructs
(1mg) or NF-kB luciferase reporter (1 mg) along with b-galactosidase
DNA (1mg, Clontech) using Lipofectamine (Invitrogen). After
transient transfection, BCC cells were serum-deprived for 24 hours
and cocultured with THP-1 macrophages for 6 hours. Cell extracts
were then prepared and the luciferase and b-galactosidase activities
were measured. The luciferase activity was normalized to the
b-galactosidase activity.
COX-2-specific RNA interference
The target sequence for the COX-2 siRNA was bases 291–313 of
NM000963.1. (50-aactgctcaacaccggaattttt-30; Denkert et al., 2003).
The COX-2 siRNA sequence was cloned into the pRNA-U6/neo
constitutively expressing vector (GenScript, Piscataway, NJ). The
COX-2 siRNA and control vectors were transiently transfected into
BCC cells before they were cocultured with macrophages.
Detection of the cytokine profile of macrophages
Culture supernatants were collected from PMA-treated THP-1
macrophages or M1/M2-polarized THP-1 macrophages at 24 hours.
Culture supernatants were collected from monocyte-derived M1/M2
macrophages 72 hours after either LPS/IFN-g (M1) or IL-4/IL-13 (M2)
were added to the macrophages. The cytokine levels were measured
with TNF-a, IL-1b, IL-6, and TGF-b EIA kits (all from R&D Systems).
Detection of VEGF-A, bFGF, and MMP-9 released from BCC
cells
BCC cells were cocultured with either PMA-treated THP-1 macro-
phages for 6 hours or monocyte-derived M2 macrophages for
24 hours. After coculture, macrophages were discarded. BCC cells
were washed and serum-free RPMI 1640 were added to BCC cells.
The serum-free supernatants were collected at 24 hours and
subjected to ELISA assays for VEGF-A, bFGF, and MMP-9.
In vitro angiogenesis assay
After BCC cells were cocultured with THP-1 macrophages for
6 hours or monocyte-derived M2 macrophages for 24 hours, macro-
phages were removed. BCC cells were washed and fresh media
added. After 24 hours, collected culture supernatants were desig-
nated as conditioned media and concentrated 10-fold. HUVECs
were isolated and cultured as previously described (Jee et al., 2004).
HUVECs (1 104 cells in 50 ml per well) were seeded into a
Matrigel-coated (50 ml per well) 96-well plate. Then, 50 ml of 10-fold
concentrated conditioned media were added to the HUVECs and
incubated for 6 hours at 37 1C. Tube-like structures of HUVECs
formed at 6 hours were counted under a microscope.
Invasion assay
The invasion assay was conducted using Transwell cell culture
chambers (24 wells, 8mm pore size; Corning). Briefly, upper inserts
were coated with 50 ml of different extracellular matrix components,
including 10mgml1 Matrigel (BD Biosciences), 0.2mgml1 gelatin
(Sigma; St Louis, MO, USA), 0.1mgml1 fibronectin (Sigma), or
0.2mgml1 collagen I (Sigma), and allowed to set for 1 hour at
37 1C. BCC cells were harvested after 6 hours of coculture with PMA-
treated THP-1 macrophages or 24 hours of coculture with monocyte-
derived M2 macrophages. Then, 1 105 BCC cells were resus-
pended in 200 ml of RPMI 1640 supplemented with 10% FCS, and
added to the upper inserts. RPMI 1640 (500 ml) with 10% FCS was
added to the lower chamber. After BCC cells attached, the media
(upper and lower chambers) were changed to serum-free RPMI
1640. At 24 hours later, invaded cells were fixed and stained with
0.05% crystal violet. Cells on the upper surface of the insert
membrane were removed with cotton rods. The invaded cells were
counted at  200 magnification in 10 different fields for each insert.
The experiments were repeated three times.
Antibodies and reagents
See Supplementary materials and methods.
Real-time quantitative PCR
See Supplementary materials and methods.
Zymography
See Supplementary materials and methods.
Statistical methods
Tests for trends were used to examine trends among the ordered
groups. The Wilcoxon rank-sum test was used to compare
nonparametric continuous variables of different groups. The
Kruskal–Wallis test was used to determine the association between
categorical variables. Multivariate linear regression was applied to
test independent influencing factors. All tests were two-sided, and a
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P-value of o0.05 was considered statistically significant. All
statistical tests were performed using STATA 8.0 software (StataCorp,
College Station, TX).
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Supplementary Materials and Methods
Table S1. Increased epithelial MMP-9 expression was associated with
increased depth of invasion, number of TAM, and epithelial COX-2
expression in BCC.
Figure S1. Experimental protocols for generating PMA-treated THP-1
macrophages, M2-polarized THP-1 macrophages and coculture experiments.
Figure S2. PMA-treated THP-1 macrophages induced COX-2 expression in
BCC cells via p38 MAPK and NF-kB activation.
Figure S3. Monocyte-derived M2 macrophages secrete low TNF-a, IL-1b, and
IL-6 and high TGF-b.
Figure S4. Coculture with monocyte-derived M2 macrophages induced COX-
2-dependent MMP-9, VEGF-A, bFGF release from BCC cells.
Figure S5. BCC cells were activated by macrophage activity but not directly
by PMA.
Figure S6.MMP-9 secretion and enzymatic activity induced by coculture with
PMA-treated THP-1 macrophages was regulated by p38 MAPK/NF-kB/COX-2
signaling cascades.
Figure S7. MMP-9 was strongly expressed in epithelial cells of aggressive
subtypes of human BCC.
Figure S8. In vitro angiogenesis, VEGF-A, and bFGF secretion induced by
coculture with PMA-treated THP-1 macrophages were regulated by the p38
MAPK/ NF-kB/COX-2 pathway.
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